FGFR3 and Tp53 Mutations in T1G3 Transitional Bladder Carcinomas: Independent Distribution and Lack of Association With Prognosis

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-0122
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

BCL6 Gene Mutations in Transitional Cell Carcinomas

Journal of International Medical Research
BiochemistryMedicineCell Biology
2007English

TP53 Codon 72 Polymorphism Is Associated With FGFR3 and RAS Mutation in Non-Muscle-Invasive Bladder Cancer

PLoS ONE
Multidisciplinary
2019English

ARID1A Alterations Are Associated With FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors

PLoS ONE
Multidisciplinary
2013English

Suppression of FGFR3- And MYC-dependent Oncogenesis by Tubacin; Association With HDAC6-dependent and Independent Activities

Oncotarget
Oncology
2017English

The P53 Pathway and Outcome Among Patients With T1G3 Bladder Tumors

Clinical Cancer Research
Cancer ResearchOncology
2006English

Spontaneous Intraperitoneal Rupture of the Bladder in Association With Transitional Cell Carcinoma.

Postgraduate Medical Journal
Medicine
1988English

Androgen Receptor Levels and Association With PIK3CA Mutations and Prognosis in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

PLoS ONE
Multidisciplinary
2010English

Somatic Mutations of Fibroblast Growth Factor Receptor 3 (FGFR3) Are Uncommon in Carcinomas of the Uterine Cervix

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy